Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000038

PRESIDENT AND CFO sold 8,000 shares at an average $81.17 ($649,325)

  • PRESIDENT AND CFO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Option exercise 10b5-1 +8,000 $5.35 $42,800 104,720 D
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Sale 10b5-1 −3,095 $80.12 $247,956 101,625 D
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Sale 10b5-1 −2,500 $81.06 $202,638 99,125 D
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Sale 10b5-1 −1,479 $82.32 $121,747 97,646 D
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Sale 10b5-1 −926 $83.14 $76,985 96,720 D
Derivatives
GUGGENHIME ANDREW PRESIDENT AND CFO 2024-07-18 Option exercise · Stock Option (right to buy) 10b5-1 −8,000 336,827 D
Open-market sales · 8,000 sh · avg $81.17 · $649,325
Loading xslF345X05/wk-form4_1721678591.xml…